Last updated on March 2019

A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment


Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Hospital Las Higueras /ID# 167091
Talcahuano, Chile
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.